YOON&YANG

본문

Young Sun Cho Partner

TEL 82 2 6003 7518
FAX 82 2 6003 7832
E-MAIL ycho@yoonyang.com

Young Sun Cho is a partner at Yoon & Yang LLC, and his main practice areas include advisory service on foreign entity’s domestic investment and M&A, foreign direct investment, and related to the healthcare industry including pharma companies.
Mr. Cho has extensive experience in assisting domestic and foreign clients (i.e., Tyson, Nike, Dell, and Burberry) with legal advice on foreign investment, joint venture, M&A, and foreign direct investment, as well as diverse statutes and regulations related to the healthcare industry (i.e., pharmaceuticals, bio, medical device, food, and cosmetics). He is admitted to practice in both Korea and New York.

Experience

2008-present Yoon & Yang LLC
2011-present Member, International Committee, Korea Bar Association
2010-present Legal Advisor, Committee for International Investment Disputes, Ministry of Justice
2004-05 Paul, Weiss, Rifkind, Wharton & Garrison (New York)
2000-08 Yulchon LLC
1997-00 Judge Advocate, Republic of Korea Navy

Education

2004 University of Pennsylvania Law School, LL.M.
1998 Seoul National University Graduate School, Department of Law (coursework completed)
1997 Judicial Research and Training Institute
1994 Seoul National University College of Law, LL.B.

Representative Matters

[Inbound Investment and Foreign Direct Investment]

Advised and represented a major coffee company on the entry into the Singaporean market
Advised and represented a major domestic franchise company on the entry into the Indonesian market
Advised and represented a major online game company on the establishment of an online game joint venture corporation in China
Advised and represented Daewoo International on the investment in a nickel mine in Madagascar
Represented a major defense company on the purchase of military goods of the Defense Acquisition Program Administration
Advised a major overseas sporting goods company on operation of joint venture and dispute between shareholders
Advised and represented a major domestic furniture company on an arbitration case before the United States AAA related to an overseas investment
Advised and represented the Korea Water Resources Corporation on the investment in the nuclear plant development project by Areva (France)
Advised and represented a Singaporean state-run fund (Mapletree Investments) on the acquisition of a domestic logistics company
Advised and represented Lotte E&C regarding the Pangyo Alpha Dome City Project
Advised and represented the National Pension Service on the acquisition of Sony Center located in Berlin (Germany)
Advised and represented a major domestic securities firm regarding a high-rise residential building development project in Malaysia
Advised a major overseas investment bank regarding the acquisition of a major office building at the city center of Seoul

[Healthcare Industry]

Advised a major pharmaceutical company on the registration on the list of products eligible for health insurance coverage, pricing, and registration on the Green List of an orphan drug
Advised a domestic biopharmaceutical company on the registration on the list of products eligible for health insurance coverage, and pricing of stem cell treatment drugs
Advised a domestic bio pharma company on COVID-19 vaccine development and supply
Advised and represented a major multinational pharmaceutical company on the drug-approval patent linkage system
Advised a major multinational pharmaceutical company on a global M&A of a specific pharmaceutical business unit
Advised and represented a multinational food company on domestic regulations
Advised a multinational food company on the launching of an ice cream business
Advised and represented a multinational medical waste disposal company on domestic regulations
Advised a major domestic bakery on an overseas market entry
Advised on the establishment of Korea’s first ever fund specific to the pharmaceutical industry (Global Pharmaceutical Fund), which the Ministry of Health and Welfare and the Korea Finance Corporation invested in for the purpose of supporting an overseas market entry of the pharmaceutical industry
Advised a global pharmaceutical fund and a major domestic pharmaceutical company on the investment of shares in a United States-based biopharmaceutical company
Advised a major multinational medical equipment company on business transfer of a domestic medical device maker
Represented a multinational corneal bank to provide various legal advice, including a legal consultation on the establishment of a corneal bank in Korea

Awards

Leading Individual, Real estate, Chambers and Partners Asia-Pacific (2014)
Leading Lawyer, Real estate, M&A, asialaw (2012, 2013)

Publications

Latest Legislative Trends regarding Patent-Pharmaceutical Product Approval Linkage, KGCCI (2015)
Korea Chapter, Overview and Implications of the Drug Patent-Approval Linkage System in South Korean Regulation, Practical Law Multi-jurisdictional guide: Life Science, Thomson Reuters (Co-author, 2014)